首页 - 基金 - 华夏创新医药龙头混合A(012981) - 资产配置
华夏创新医药龙头混合A(012981)资产配置
序号 报告期 股票占净比(%) 债券占净比(%) 现金占净比(%) 净资产(元)
1 2026-03-31 91.42 - 7.92 259,984,405.06
2 2025-12-31 89.21 - 13.40 212,524,902.36
3 2025-09-30 93.73 - 10.62 225,209,590.90
4 2025-06-30 91.88 - 11.15 212,063,239.77
5 2025-03-31 92.34 - 10.02 176,662,346.96
6 2024-12-31 85.81 - 16.21 151,053,791.70
7 2024-09-30 93.22 0.06 11.26 173,836,742.92
8 2024-06-30 90.41 - 9.70 160,629,259.53
9 2024-03-31 87.74 - 13.11 177,835,654.33
10 2023-12-31 88.25 - 17.07 207,673,977.56
11 2023-09-30 91.38 - 11.90 204,288,407.94
12 2023-06-30 89.45 0.07 13.07 209,119,464.10
13 2023-03-31 87.25 - 13.27 210,135,125.06
14 2022-12-31 90.53 - 8.31 210,027,586.21
15 2022-09-30 88.11 - 11.49 170,811,801.15
16 2022-06-30 88.80 - 10.79 188,887,397.47
17 2022-03-31 88.00 - 10.84 179,128,831.74
18 2021-12-31 77.79 0.02 26.77 193,750,328.76
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-